Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes?

  • Anna A Porwit
  • Published 2015 in Current hematologic malignancy reports

Abstract

This review focuses on the most recent literature concerning flow cytometry (FCM) application for diagnosis of myelodysplastic syndrome (MDS). Aberrant FCM results have been defined as abnormalities in at least three tested features comprising at least two bone marrow (BM) cell compartments. FCM results should be interpreted together with the BM smear… (More)
DOI: 10.1007/s11899-015-0272-3

Topics

3 Figures and Tables

Cite this paper

@article{Porwit2015IsTA, title={Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes?}, author={Anna A Porwit}, journal={Current hematologic malignancy reports}, year={2015}, volume={10 3}, pages={309-17} }